Business Segments Vanda Pharmaceuticals Inc.
Equities
VNDA
US9216591084
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.020 USD | -1.18% | -5.10% | +18.96% |
07-31 | Transcript : Vanda Pharmaceuticals Inc., Q2 2024 Earnings Call, Jul 31, 2024 | |
07-31 | Earnings Flash (VNDA) VANDA PHARMACEUTICALS Reports Q2 Revenue $50.5M, vs. Street Est of $47.9M | MT |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Biotechnology (Startups) | 227M | 248M | 269M | 254M | 193M | |||||
Total Assets | 484M | 533M | 594M | 634M | 648M | |||||
Income Tax Expense | -86.52M | 8.32M | 9.21M | 5.02M | 3.83M | |||||
CAPEX | -1.02M | -1.8M | -552K | -679K | -101M | |||||
EBT | 29.03M | 31.66M | 42.36M | 11.3M | 6.34M | |||||
D&A | 2.89M | 2.86M | 2.84M | 2.73M | 3.01M | |||||
Operating Income | 22.81M | 27.24M | 42.16M | 6.33M | -13.95M | |||||
Net Income | 116M | 23.34M | 33.15M | 6.28M | 2.51M |
Geographical Revenue Distribution History
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
United States | 227M | 248M | 269M | 254M | 193M | |||||
Total Assets | 484M | 533M | 594M | 634M | 648M | |||||
Income Tax Expense | -86.52M | 8.32M | 9.21M | 5.02M | 3.83M | |||||
D&A | 2.89M | 2.86M | 2.84M | 2.73M | 3.01M | |||||
CAPEX | -1.02M | -1.8M | -552K | -679K | -101M | |||||
Net Income | 116M | 23.34M | 33.15M | 6.28M | 2.51M | |||||
EBT | 29.03M | 31.66M | 42.36M | 11.3M | 6.34M | |||||
Operating Income | 22.81M | 27.24M | 42.16M | 6.33M | -13.95M |
- Stock Market
- Equities
- VNDA Stock
- Financials Vanda Pharmaceuticals Inc.
- Business Segments
MarketScreener is also available in this country: United States.
Switch edition